Nitric oxide and TGF-beta1 inhibit HNF-4alpha function in HEPG2 cells

Area of Science:

• Hepatology
• Molecular Biology
• Cellular Signaling

Background:

• Liver fibrosis is characterized by impaired liver function.
• Profibrogenic factors like TGF-beta1 and nitric oxide are implicated in fibrosis progression.
• Hepatocyte nuclear factor-4alpha (HNF-4alpha) is a key regulator of liver-specific gene expression.

Purpose of the Study:

• To investigate the impact of TGF-beta1 and nitric oxide on HNF-4alpha function.
• To elucidate the molecular mechanisms by which these factors affect HNF-4alpha activity.
• To understand the role of HNF-4alpha dysfunction in liver fibrosis.

Main Methods:

• HepG2 cells were treated with TGF-beta1 or a nitric oxide donor.
• mRNA levels of coagulation factor VII and HNF-4alpha were quantified.
• Chloramphenicol acetyl-transferase assays assessed factor VII gene promoter activity.
• Gel shift assays and Western blot analyzed HNF-4alpha DNA binding and protein levels.

Main Results:

• Both TGF-beta1 and nitric oxide downregulated factor VII mRNA.
• This downregulation was mediated by inhibition of the factor VII gene promoter.
• HNF-4alpha DNA binding decreased, indicating reduced HNF-4alpha activity.
• TGF-beta1 induced HNF-4alpha degradation, while nitric oxide caused nitrosylation.

Conclusions:

• TGF-beta1 and nitric oxide inhibit HNF-4alpha activity through distinct mechanisms.
• Impaired HNF-4alpha function contributes to the loss of liver functions during fibrosis.
• These findings provide insights into the molecular pathology of liver fibrosis.